- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Schizophrenia
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Aripiprazole – July 2025
Aripiprazole; Powder for injection 300 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe, Powder for injection 400 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe; Abilify Maintena®
Last updated
9 July 2025
